KLP Kapitalforvaltning’s Tourmaline Bio TRML Stock Holding History

KLP Kapitalforvaltning’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,300	Closed	-$110K	–	2219
2025 Q3	$110K	Hold	2,300	–	–	﹤0.01%	2043
2025 Q2	$36.8K	Hold	2,300	–	–	﹤0.01%	2177
2025 Q1	$35K	Hold	2,300	–	–	﹤0.01%	2229
2024 Q4	$46.6K	Buy	+2,300	New	+$57.9K	﹤0.01%	2248

KLP Kapitalforvaltning's TRML Position: Q4 2025 in Review

KLP Kapitalforvaltning sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 2,300 shares — an estimated $110K sold.

KLP Kapitalforvaltning first reported a position in TRML in Q4 2024 and held it in 4 quarters. The position peaked at $110K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

KLP Kapitalforvaltning reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
KLP Kapitalforvaltning sold 2,300 Tourmaline Bio shares in Q4 2025, an estimated $110K.
KLP Kapitalforvaltning first reported a position in Tourmaline Bio in Q4 2024 and held it in 4 quarters.
KLP Kapitalforvaltning's Tourmaline Bio position peaked at $110K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on KLP Kapitalforvaltning's 13F filing for Q4 2025, filed 28 Jan 2026.